← FDA Drug Approvals (Drugs@FDA)
HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1978-04-21
Drug application
- FDA Application #
ANDA085771- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE
- Generic name
- Hydralazine Hydrochloride
- Active ingredients
- HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- WATSON LABS
- First approval
- 1978-04-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown